HBM Healthcare Investments

HBM Healthcare Investments

Investing in drugs and technologies of tomorrow

Corporate | Global | Health Improvement

 

Overview

HBM Healthcare Investments actively invests in the human medicine biotechnology medical technology and diagnostics sectors and related areas. The company holds and manages an international portfolio of promising companies. Many of these companies have their lead products already available on the market or at an advanced stage of development. The portfolio companies are closely tracked and actively guided on their strategic directions. This is what makes HBM Healthcare Investments an interesting alternative to investing in big pharma and biotech companies. HBM Healthcare Investments has an international shareholder base and is listed on SIX Swiss Exchange (ticker HBMN).

Investor Type

Legal Structure

Operating Status

Members

Corporate C Corporation Operating

Portfolio

Aug, 2017

 $15M Series C +

1mg Technologies

Purchase Medicines & Drugs Online in India

1mg is India's leading consumer health platform. It aspires to...

sector

Health Improvement

regions

India

People

Prashant Tandon
Tanmay Saksena
Alankrit Nishad


Investors / Funders


Team


Funds


Impact

Geographies:

Social Objectives:

Environmental Objectives:


Operational Impact:


Impact Reports & Metrics


Offices

Bundesplatz 1
P.O. Box 1145
CH-6301 Zu
Switzerland



Explore

Revision History

Last Update: Aug 20, 2017 12:00 a.m.

Quick Search



  • Global  
  • Africa  
  • Americas  
  • Asia  
  • Europe  
  • Oceania  


Incoming

Tags

COPYRIGHT 2018 IMPACTSPACE. ALL RIGHTS RESERVED.